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ABSTRACT 
 
Due to its natural fluorescence, Green Fluorescent Protein (GFP) is a preferred 
reporter protein for cellular localization studies.  For use in nuclear localization studies, a 
fusion protein consisting of multiple copies of GFP must be used to eliminate simple 
diffusion as a mechanism through which the protein can enter the nucleus.  The long-term 
goal of this research project is to create a plasmid expression vector containing three copies 
of the GFP gene linked to a single monopartite nuclear localization signal (3GFP-1NLS) and 
containing the commonly used pCMV eukaryotic promoter.  The specific objective of the 
research study reported here was to create an intermediate plasmid, containing three copies of 
the GFP gene, from which the 3GFP-1NLS plasmid could be eventually produced.  Using 
site-directed mutagenesis techniques, the parent plasmid used in this study, the 
pCMV/myc/nuc/GFP pShooter plasmid (Life Technologies, Inc.), was modified to create 2 
intermediate plasmids, one serving as a vector and the other serving as a source for a single 
copy GFP insert. The restriction enzyme PstI was then used to successfully open the vector 
and isolate the insert. After multiple attempts, GFP insert has been successfully ligated into 
the vector creating the intermediate plasmid, 2GFP-3NLS. Again, using site-directed 
mutagenesis and restriction endonuclease digestion techniques, the 2GFP_3NLS plasmid was 
modified to create 2 intermediate plasmids, one serving as a vector and the other serving as a 
source for a single copy GFP insert. The restriction enzyme PacI was then used to 
successfully open the vector and isolate the insert. After multiple attempts, the GFP insert has 
been successfully ligated into the vector creating the 3GFP-3NLS. This plasmid will lead to 
the eventual production of the final 3GFP-1NLS plasmid.  Once produced, the final plasmid 
could be used to study various aspects of NLS-dependent nuclear import.
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Introduction 
 
 
Nucleocytoplasmic Transport 
 
 
Nucleocytoplasmic transport is the bidirectional transport of a variety of molecules 
between the nucleus and cytoplasm of eukaryotic cells. The unique structure of the nucleus 
results from the specific bidirectional transport of macromolecules across the nuclear 
envelope via nuclear pore complexes (NPCs) (Stochaf, 1992). The nucleus provides spatial 
separation of transcription and translation which facilitates the precise regulation of cellular 
processes such as gene expression (Kaffman, 1999), signal transduction (Cyert, 2001), and 
cell cycle progression (Johnson et al., 2004) through selective regulation of bidirectional 
transport between nucleus and cytoplasm. This provides eukaryotes with powerful 
mechanisms for controlling gene expression, but also requires selective transport between the 
nuclear and cytoplasmic compartments to maintain the distinctive composition of each 
(Stewart, 2007).  Molecules that are exported out of the nucleus include large and small 
ribosomal subunits and messenger RNA among other things. Molecules that are imported 
into the nucleus include transcription factors, histones, and DNA polymerase among other 
things (Alberts, 2008). 
 
There are two mechanisms for the transport of macromolecules across the nucleus: 
simple/passive diffusion and facilitated translocation. Prior studies show that ions and 
proteins smaller than approximately 70,000 Da can diffuse through the NPC into the nucleus 
through simple/passive diffusion and molecules larger than approximately 70,000 Da, such 
as proteins, are completely excluded from the nucleus (Paine, 1975).  Ions and small proteins, 
 
50,000 Da or less, diffuse into the nucleus so rapidly that the nuclear envelope can be 
considered freely permeable to them. Studies conducted by Feldherr and Akin (1997)
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concluded that there is only a single diffusion channel traversing the center of the NPCs 
through which simple/passive diffusion and facilitated translocation take place. This was also 
confirmed by the studies conducted by Keminer and Peters (1999) in which they determined 
the radius of the NPCs as well. They showed that the NPCs have a 5-nm radius and a length 
of 45-nm. Therefore, these measurements determine the cut off size for proteins that can 
simply/passively diffuse into the nucleus. A more recent study determined the diameter of 
human NPCs to be approximately 9nm therefore this is the limit of simple diffusion; 
molecules larger than that cannot simply/passively diffuse (Mohr, 2009). 
 
The NPC structure also determines the rate at which molecules can diffuse through it. 
The size/molecular weight of a molecule is inversely related to its rate of diffusion into the 
nucleus. In other words, the smaller molecules have a faster diffusion rate and large 
molecules have a slower rate of diffusion. Proteins larger than 60,000 Da can barely enter by 
passive diffusion and proteins that are 70,000 Da or more are excluded from the nucleus 
(Albert, 2008), implying that the size cut-off for simple diffusion falls between 60,000 to 
70,000 Da. This size constraint determines the distribution of proteins between the nucleus 
and cytoplasm. 
 
Transport of large proteins, >70,000 Da, requires the presence of a specific targeting 
signal within the primary sequence to get through the NPC (Kalderon et al., 1984). This 
specific targeting signal is called the nuclear localization signal (NLS) and is located within 
the primary structure of the target protein. Presence of an NLS protein allows the rapid 
accumulation of any sized protein in the nucleus at high concentration (Cook et al. 2007). 
This signal-dependent transport system is a bidirectional selective process because some
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molecules are only imported, others only exported while others are shuttled in and out of the 
nucleus (Keminer and Peters, 1999). 
 
The NLS is a relatively short sequence of amino acids embedded in the primary 
structure of a protein that initiates an interaction between the protein and a special facilitated 
transport mechanism, called nuclear import, resulting in the active transport of the protein 
through the NPC (Cook et al. 2007). Soluble carrier proteins facilitate the active transport of 
protein cargo between the cytoplasmic and nuclear compartments. These carriers are 
collectively known as karyopherins (Radu et al., 1995). The karyopherins involved in the 
import of molecules are referred to as importins (Gorlich et al., 1994) and the karyopherins 
for export are referred to as exportins (Stade et al., 1997). The distinction between the 
karyopherins may be artificial though, because in an ideal system, a transport factor would 
import one molecule, switch to export mode, and then return to the cytoplasm carrying a 
different cargo (Lange et al., 2007). 
 
The general mechanism for the transport of a large protein into the nucleus begins 
when an importin discriminates between its cargo and other cellular proteins. The importins 
bind to a cargo protein containing an NLS and transport it towards the NPCs. The cargo 
protein then binds to tentacle-like fibrils that extend from the rim of the NPC into the 
cytoplasm and then proceeds though the center of the NPC. The way that macromolecular 
transport across NPCs differs from the transport of proteins across the membrane of other 
organelles is that the proteins diffuse through a large aqueous pore rather than though a 
protein transporter located in the lipid bilayer of the cell. This is the reason why fully folded 
nuclear proteins can be transported into the nucleus through an NPC, and newly formed
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ribosomal subunits are transported out of the nucleus as an assembled particle (Alberts, 
 
2008). 
 
 
The mechanism of the nuclear protein import process specifically involves an import 
complex that is formed in the cytoplasm between cargo proteins bearing nuclear localization 
signals (NLSs), importin-α and importin-β. After passing through the nuclear pore complex 
(NPCs), the binding of RanGTP to importin-β dissociates importin-β from importin-α. The 
NLS-containing cargo is then displaced from importin-α and the importin-α is recycled to the 
cytoplasm by its nuclear export factor, CAS, complexed with RanGTP. In the cytoplasm, 
RanGAP stimulates GTP hydrolysis, releasing the importins for another import cycle. 
Nucleoporins such as NUP50 catalyse cargo dissociation and function as molecular ratchets 
to prevent futile cycles. Ran also cycles between the nucleus and cytoplasm and, because the 
Ran guanine nucleotide-exchange factor (RanGEF) is nuclear and Ran GTPase activating 
protein (RanGAP) is cytoplasmic, this cycle is associated with changes in the nucleotide 
state. Therefore, cytoplasmic RanGDP is imported into the nucleus by nuclear transport 
factor-2, a nuclear import factor committed to the import of RanGDP into the nucleus, where 
RanGEF catalyses nucleotide exchange and generates RanGTP. RanGTP then binds to 
transport factors, such as importin-β and CAS (an importin- α nuclear export factor), and is 
exported to the cytoplasm, where RanGAP stimulates GTP hydrolysis. (Stewart, 2007). The 
import and accumulation of NLS cargo in the nucleus is affected by both the affinity of the 
NLS cargo for importin and by the concentration of the importin receptor itself (Riddick and 
Macara, 2005).
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Monopartite Nuclear Localization Signal 
 
 
The nuclear localization signals (NLSs) can be classified as either monopartite or 
bipartite NLSs. A monopartite NLSs consist of a single stretch of 7-9 amino acids. The 
bipartite NLS consists of two stretches of 16 amino acids separated by a 10-12 amino acid 
linker region. The simian virus large T-antigen (SV40 TAg, 81,500 Da) NLS is the 
established monopartite NLS (Lange et al., 2010). The SV40 TAg large T antigen, a 
predominantly nuclear protein that performs essential regulatory tasks in viral growth and 
that is able to act as an oncoprotein in many animal cells (Fischer-Fantuzzi and Vesco, 1988), 
carries one of the best-defined signals, a short stretch of mostly basic amino acids (Pro-Lys- 
Lys-Lys-Arg-Lys-Val), occupying positions 126 to 132 in the polypeptide chain. The 
insertion of such a codon sequence into the coding sequences of some cytoplasmic proteins 
has been shown to be enough for the nuclear targeting of these proteins (Kalderon et al., 
1984). 
 
 
The discovery and initial characterization of the monopartite NLS came, in part, from 
studies that used plasmid expression vectors containing the code for the SV40 TAg which 
naturally contains an NLS, and from studies using plasmids containing a monopartite NLS 
fused to β-galactosidase (β-gal, 116,000 D) (Kalderon et al. 1984).  Considering that research 
into the nuclear import mechanism requires reporter proteins that are unable to enter the 
nucleus by diffusion (Chatterjee et al. 1997), both TAg and the β-gal-NLS fusion protein are 
suitable reporter proteins for studying NLS-dependent nuclear import since both are too large 
to diffuse across the nuclear envelope. If there is an undesirable aspect to the use of TAg and 
the β-gal-NLS as reporter proteins, it would be that their detection within cells requires
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relatively time-intensive indirect immunofluorescence assays involving cellular fixation, 
permeabilization and a double-staining protocol (Kalderon et al.1984). 
 
Green fluorescent Protein and Plasmid expression vector 
 
 
Green Fluorescent Protein (GFP) is extracted from the jellyfish Aequorea victoria, 
and emits intrinsic intense and stable greenish fluorescence without any additional cofactors. 
GFP is a monomeric protein consisting of 238 amino acids that forms a tertiary structure 
known as beta barrel, which is a common structure shared by many other fluorescent 
proteins. In GFP, the barrel consists of 11 beta chains and includes an alpha helix which 
crosses the barrel along its entire length. Three consecutive amino acids in the alpha helix 
form a natural chromophore, so when GFP is illuminated with ultraviolet light, it produces a 
bright green fluorescence (Arai et al., 2001). 
 
GFP offers an attractive alternative to TAg and β-gal-NLS as a cellular reporter 
protein.  GFP exhibits bright green fluorescence when exposed to light in the blue 
to ultraviolet range, requires no exogenous substrates or cofactors, is easily detected in 
eukaryotic cells using fluorescence microscopy and is considered an ideal reporter protein for 
cellular localization studies (Prasher et al. 1992; Chalfie 1995; Kain et al. 1995). GFP has 
been widely used for monitoring gene expression as a reporter protein, studying the 
subcellular localization of cellular proteins in living cells (Tsien, 1998), and performing 
fluoroimmunoassays (Arai et al., 2001). 
 
GFP has its biggest absorbance peak is at 395 nm, with a smaller peak at 475 nm, and 
the emission maximum is at 508 nm when excited at 395 nm (Arai, 2001). Unlike other 
bioluminescent reporters, the chromophore in GFP is intrinsic to the primary structure of the
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protein and GFP fluorescence does not require a substrate or cofactor, as mentioned (Kain, 
 
1995). Another advantage to using GFP as the reporter protein for this study is that GFP 
fluorescence is stable, species-independent and can be monitored non-invasively in living 
cells as GFP is easily detected in cells using fluorescence microscopy. 
 
A limitation of GFP as a reporter protein for use in NLS-dependent nuclear import 
studies is that at 28,894 D, GFP is small enough to move through the nuclear pore complex 
and enter the nucleus via simple diffusion.  This has been confirmed by the studies of Bond 
(2014) and Krumpos (2014), which showed that in the absence of a nuclear localization 
signal, GFP appears in both the cytoplasm and nucleus of transfected Human Embryonic 
Kidney (HEK) Cells.  To eliminate simple diffusion as a way of getting into the nucleus, 
Chatterjee et al. (1997) created expression vectors that contain four copies of the GFP gene, 
expressing a fused GFP with a molecular weight of approximately 107,000 Daltons, and 
showed that in the absence of an NLS, the protein was too large to diffuse into the nucleus. 
 
One undesirable feature of the plasmid created by Chatterjee et al. (1997) is that it 
contains an inducible promoter, that is, a gene promoter that must be induced by a chemical 
inducer for gene expression to occur (Feinbaum 1998). The promoter used in the Chatterjee 
et al. plasmid contains a glucocorticoid response element that requires dexamethasone for 
induction and eventual expression of GFP (Chatterjee et al. 1997).  The long-term goal of our 
research is to create a plasmid similar to the Chatterjee et al. plasmid, but containing a 
multiple cloning site containing 3 copies of the GFP open reading frame (ORF) linked to a 
single NLS (3GFP_1NLS) and controlled by a promoter that does not require chemical 
induction, resulting in the strong constitutive expression of the GFP fusion protein.
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The parent plasmid used in this study, the pShooter pCMV/myc/nuc/GFP plasmid, is 
a commercially-available plasmid, developed by Life Technologies, from which our target 
3GFP_1NLS plasmid is being built.  The pCMV/myc/nuc/GFP plasmid is a 5.7 kb plasmid 
with a multiple cloning site that is controlled by the CMV promoter (5’ end of the entire 
plasmid genome), a strong constitutive promoter, and the code for 1 GFP ORF (717 bases, 
coding for 238 amino acid residues) linked to 3 tandemly-arranged copies of an NLS 
(1GFP_3NLS, Life Technologies, Inc. 2012) refer to Figure 1 for the sequence of this parent 
plasmid.  Other unique features of this plasmid include: the multiple cloning site to allow the 
insertion of the GFP ORF, the CMV priming site used multiple times to sequence mutated 
plasmids, the TAG termination codon for efficient termination of translation, Bovine growth 
hormone (BGH) polyadenylation signal allows efficient transcription termination and 
polyadenylation of mRNA (Goodwin and Rottman, 1992), the BGH Reverses priming site 
another site used to sequence mutated plasmids, the pUC origin for high-copy number 
replication and growth in E. coli, and the Ampicillin resistance gene for selection of the 
mutated plasmid vector in E. coli. 
 
While 1 NLS is all that is required by native proteins to be completely localized to the 
nucleus, 3 copies of an NLS are included in the pCMV/myc/nuc/GFP plasmid to ensure 
complete nuclear localization of any non-native, plasmid-derived fusion protein that an 
investigator would be interested in studying (Fischer-Fantuzzi and Vesco 1988). In other 
words, the NLS sequence is triplicated to ensure proper localization of the protein of interest 
in the nucleus. Since the future purpose of this research is to study the NLS, the model 
system had to be modified to contain an expressed fusion protein large enough to inhibit 
simple diffusion but still behave like native proteins that are localized into the nucleus.
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Hypothesis/objective 
 
 
The specific objective of the research study proposed here was to modify the 
commercially-available pCMV/myc/nuc/GFP plasmid (1GFP_3NLS) to create two new 
plasmids, one containing 2 copies of the GFP ORF linked to 3 NLSs (2GFP_3NLS) and one 
containing 3 copies of the GFP ORF linked to 3 NLSs (3GFP_3NLS). Once completed, a 
future study would involve removing 2 of the NLSs from the 3GFP_3NLS plasmid to 
produce the final 3GFP_1NLS plasmid. This final plasmid, 3GFP_1NLS would contain all 
the necessary components to study the nuclear import process and the NLS, because in nature 
the normal physiological nuclear import process only requires the presence of one NLS. 
 
Materials and Methods 
 
 
Experimental Design. The specific objective of this research was to modify the 
commercially-available pCMV/myc/nuc/GFP plasmid, consisting of 1GFP at 5’ end of the 
transcript linked downstream to 3NLS at the 3’ end of the transcript to create two new 
plasmids, one containing 2 copies of the GFP ORFs linked to 3 NLSs (2GFP_3NLS) and one 
containing 3 copies of the GFP ORF linked to 3 NLSs (3GFP_3NLS). To create the 
2GFP_3NLS plasmid a 48 base pair linker was inserted upstream of the parent GFP ORF. 
Then, a second copy of a GFP ORF was added upstream of that 48 base pair linker. To create 
the 3GFP_3NLS plasmid a 24 base pair linker was added upstream of the second GFP ORF. 
Then a third copy the GFP ORF was added upstream of the 24 base pair linker. 
 
Creation of the 2GFP_3NLS plasmid. To create the 2GFP_3NLS plasmid, the 
parent plasmid, pCMV/myc/nuc/GFP (1GFP_3NLS), was modified by inserting a second 
copy of the GFP ORF separated by a short 48-base pair linker (Thermo FisherScientific,
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V82120). The parent plasmid was modified using Q5® Site-Directed Mutagenesis Kit Quick 
Protocol (New England BioLabs, E0554) to create two intermediate plasmids, one serving as 
a vector and the other serving as a source for a single-copy GFP insert. 
 
To create these modifications, an insertion of a 48-base pair linker was required in 
between the two GFP ORFs to ensure proper folding of the GFPs during translation. A 
commonly-used 16 amino acid glycine-rich peptide linker ((Gly-Gly-Ser-Gly) x 3), was 
inserted into the parent plasmid immediately adjacent to the upstream end of the GFP ORF. 
As mentioned, this 48-base pair linker was used as a spacer separating the GFP ORF from 
the to-be-inserted second copy of the GFP ORF.  The success of this linker insertion was 
confirmed with DNA sequencing. The resulting plasmid was designated pSGKK07 and 
served as the vector plasmid into which the second GFP ORF would be inserted. 
 
To insert the second GFP ORF, site-directed mutagenesis was first used to change 
the NotI restriction endonuclease cut site (5’ GC_GGCCGC 3’), located at the downstream 
end of the GFP ORF, to a PstI restriction site (5’CTGCA_G3’). This was done using specific 
forward and reverse primers designed with the New England Biolabs BaseChanger 
Interactive Tool (New England BioLabs). Polymerase chain reaction (PCR) was performed 
using the specific annealing temperature for the primers. To circularize the plasmid and 
remove the DNA template, 1 μl of the amplified material was added directly to a micro- 
centrifuge tube containing 1 μl 10X Kinase-Ligase-DpnI (KLD) enzyme mix, 5 μl 2X KLD 
Reaction Buffer, and 3 μl Nuclease-free water for 5 minutes at room temperature. A standard 
transformation procedure was performed according to New England BioLabs’ protocol using 
NEB 5-alpha Competent E. coli cells (New England BioLabs, E0554) and cultured overnight
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to create more copies of all plasmids. This was followed by DNA isolation using a GeneJET 
 
plasmid miniprep kit (ThermoFisher Scientific, K0502). 
 
 
The resulting plasmid was designated pSGKK09 and contained a GFP ORF flanked 
on both the 5’ and 3’ ends by a PstI restriction site, thus serving as the source for the single 
GFP ORF insert. The creation of the vector plasmid and the insert plasmid was confirmed by 
gel electrophoresis and DNA sequencing. In order to insert a second GFP ORF into 
pSGKK07, the plasmid was opened at the PstI cut site by a 50 µl restriction endonuclease 
digestion reaction using the restriction enzyme PstI. PstI was also used to cut the insert 
plasmid, pSGKK09, in two places, thus removing the GFP ORF fragment. This reaction 
included adding 5 µl of DNA, 5µl 10X NEBuffer, 1µl of Pst1 Time-Saver Qualified enzyme, 
and 39 µl of distilled water to a micro-centrifuge tube and placing this in a water bath at 
37°C for 15 minutes. 
 
 
Following the restriction digestion reaction, a dephosphorylation was performed on 
the vector plasmid by adding 1/10 volume of 10X Antarctic Phosphatase Reaction Buffer to 
2.5 µg of the opened vector and 1µl of Antarctic Phosphatase to a microcentrifuge tube. The 
reaction was incubated for 15 minutes in a 37°C incubator. The digested and 
dephosphorylated vector and digested insert plasmid were then electrophoresed on a 1% 
agarose gel. Using a commercially-available QIAquick gel extraction kit (Qiagen, 28706) 
and a standard ligation protocol (New England Biolabs, M0202) by New England BioLabs, 
the opened vector and the GFP ORF insert fragment were extracted from the gel and ligated 
together. This created the 2GFP_3NLS plasmid, designated pSGKK10. This plasmid then 
served as the vector plasmid for the insertion of a third GFP ORF.
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Creation of the 3GFP_3NLS plasmid. To create the 3GFP_3NLS plasmid, the 
 
 
2GFP_3NLS plasmid was modified by inserting a third copy of the GFP ORF, separated 
from the second by a short 24-base pair linker. First, using Q5® Site-Directed Mutagenesis 
Kit Quick Protocol (New England BioLabs, E0554), a commonly-used 24-base pair glycine- 
rich peptide linker ((Gly-Gly-Ser-Gly) x 2) was inserted into the parent plasmid, 
1GFP_3NLS, immediately adjacent to the downstream end the GFP ORF; separating the 
third copy of the GFP ORF from the second copy of the GFP ORF. The success of this 
insertion mutation was confirmed with DNA sequencing.  The resulting plasmid was 
designated pSGKK04. 
 
The 2GFP_3NLS plasmid, pSGKK10 was used as the vector plasmid for inserting 
the third GFP ORF. A new set of specific forward and reverse primers were designed to 
insert a Pac1 restriction cut site (5’TTAATTAA3’) upstream of the GFP ORF in the vector 
plasmid pSGKK10 and the insert plasmid pSGKK04. 
 
Following these modifications made to the pSGKK10 and pSGKK04 plasmids they 
were re-designated pSGKK12 and pSGKK11, respectively. The new restriction 
endonuclease cut site Pac1 was used in place of Pst1 due to DNA overlap in the sequence of 
two plasmids. Another Pac1 cut site was inserted downstream of the 24-base pair linker in 
the insert plasmid, pSGKK11. The insert plasmid was now flanked by PacI restriction cut 
sites in both the 5’ and 3’ end. This plasmid was re-designated pSGKK14 and served as the 
source of the insert fragment containing a single copy of the GFP ORF with the 24-base pair 
linker. Using the methods previously described (for the 2GFP_3NLS plasmid) a third copy of 
the GFP ORF containing a 24-base pair linker was inserted into the vector plasmid, 
2GFP_3NLS, thus creating the 3GFP_3NLS plasmid, designated pSGKK15.  Creation of the
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3GFP_3NLS plasmid was confirmed by gel electrophoresis and DNA sequencing. Once 
pSGKK15 (3GFP_3NLS plasmid) was generated another site-directed mutagenesis was 
done to insert two base pairs (CA) downstream of the 24-base pair linker. This plasmid was 
re-designated pSGKK16. The success of this mutagenesis was verified by DNA sequencing. 
 
Results 
 
 
Creation of the 2GFP_3NLS plasmid. The results of this experiment were visualized 
in a 1% agarose gel electrophoresis shown in figure 2a. The results of the agarose gel run 
with the 3 plasmids, pSGKK07, pSGKK09 and pSGKK10, created in this study were cut 
with PstI, confirming the structure of each plasmid. Well 1 shows the DNA Ladder, Well 2 
shows pSGKK07 (vector plasmid), Well 3 shows pSGKK09 (insert plasmid) and Well 4 
shows pSGKK10 (2GFP_3NLS plasmid). Since pSGKK07 has only one PstI cut site, the 
restriction digestion resulted in a single band consisting of the entire plasmid (~ 5,743 bp). 
Since pSGKK09 has two PstI cut sites, restriction digestion resulted in two DNA fragments, 
the lower band is the smaller DNA fragment consisting of single GFP ORF (~ 717 bp), and 
the upper band is the rest of the plasmid (~ 4,978 bp).  Likewise, the 2GFP_3NLS plasmid 
(pSGKK10) has two PstI cut sites, and restriction digestion results in two DNA fragments. 
The lower band consists of the smaller DNA fragment containing the newly-inserted GFP 
ORF (~ 717 bp), while the upper band consists of the rest of the plasmid, including the 
original GFP ORF, the 48 bp linker that sits between the two GFP ORFs, 3 NLSs (~5,743 
bp). Figure 2b shows the restriction Map of pSGKK07, pSGKK09 and pSGKK10. Step 1 
and step 2 show pSGKK07 and pSGKK09 cut with Pst1. Step 3 shows the ligation of the 
GFP ORF into the pSGKK07 (vector plasmid) to create pSGKK10 (2GFP_3NLS plasmid).
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To confirm the structure of the 2GFP_3NLS plasmid (~6,460 bp), the plasmid was 
sent out for sequencing.  The results, shown in figure 3 confirm the presence of all expected 
features of the plasmid.  Starting at the upstream 5’ end of the sequence is the Pst1 cut site 1 
(gray), followed by the newly-inserted GFP ORF (green), followed by the Pst1 cut site 2 
(gray), the 48 bp linker (yellow) and the original GFP ORF (green).  Following the 
downstream original GFP ORF are the 3 NLSs (pink), along with other features of the 
plasmid. 
 
Creation of the 3GFP_3NLS plasmid. The results of this experiment were visualized 
in a 1% agarose gel electrophoresis shown in figure 4a. The results of the agarose gel run 
with the 3 plasmids, pSGKK12, pSGKK14 and pSGKK16, created in this study were cut 
with Pac1, confirming the structure of each plasmid. Well 1 shows the DNA Ladder, Well 2 
shows pSGKK12 (vector plasmid), Well 3 shows pSGKK14 (insert plasmid) and Well 4 
shows pSGKK16 (3GFP_3NLS plasmid). Since pSGKK12 has only one PacI cut site, the 
restriction digestion resulted in a single band consisting of the entire plasmid (~ 6,472 bp). 
Since pSGKK14 has two PacI cut sites, restriction digestion resulted in two DNA fragments, 
the lower band is the smaller DNA fragment consisting of a single GFP ORF with the 
downstream 24bp linker (~ 794 bp), and the upper band is the rest of the plasmid (~ 6,700 
bp). Likewise, the 3GFP_3NLS plasmid (pSGKK16) has two PacI cut sites, and restriction 
digestion results in two DNA fragments.  The lower band consists of the smaller DNA 
fragment containing the newly-inserted GFP ORF and the downstream 24bp linker (~ 794 
bp), while the upper band consists of the rest of the plasmid, including the original GFP 
ORF, Secondly-inserted GFP ORF, the 48 bp linker that sits between the two GFP ORFs, and 
 
3 NLSs (~6,472 bp). Figure 4b shows the restriction Map of pSGKK12, pSGKK14 and
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pSGKK16. Step 1 and step 2 show pSGKK12 and pSGKK14 cut with Pac1. Step 3 shows 
the ligation of the GFP ORF into the pSGKK12 (vector plasmid) to create pSGKK16 
(3GFP_3NLS plasmid). 
 
To confirm the structure of the 3GFP_3NLS plasmid (~7,266bp), the plasmid was 
sent out for sequencing. The results, shown in figure 5, confirm the presence of all expected 
features of the plasmid.  Starting at the upstream 5’ end of the sequence is the Pac1 cut site 1 
(purple), followed by the newly-inserted GFP ORF (green), followed by the 24 bp linker 
(yellow), followed by the Pac1 cut site 2 (purple), the second-inserted GFP ORF (green), 
the 48 bp linker (yellow) and the original GFP ORF (green).  Following the downstream 
original GFP ORF are the 3 NLSs (pink), along with other features of the plasmid. 
 
Discussion 
 
 
The objective of this research study was successfully accomplished. The 
commercially-available pCMV/myc/nuc/GFP plasmid (1GFP_3NLS), the parent plasmid, 
was successfully modified and used to create two new plasmids, one containing 2 copies of 
the GFP ORFs linked to three tandemly-arranged NLSs (2GFP_3NLS) and one containing 3 
copies of the GFP ORF linked to three tandemly-arranged NLSs (3GFP_3NLS). 
 
Prior studies performed by Bond (2014) and Krumpos (2014) showed that in the 
absence of a nuclear localization signal, GFP appears in both the cytoplasm and nucleus of 
transfected Human Embryonic Kidney (HEK) Cells. A limitation of GFP as a reporter 
protein for use in NLS-dependent nuclear import studies is that at 28,894 D, GFP is small 
enough to move through the nuclear pore complex and enter the nucleus via simple diffusion. 
To eliminate simple diffusion as a way of getting into the nucleus, Chatterjee et al. (1997)
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created expression vectors that contain four copies of the GFP gene, expressing a fused GFP 
with a molecular weight of approximately 107,000 Daltons, and showed that in the absence 
of an NLS, the protein was too large to diffuse into the nucleus. 
 
The fusion protein expressed by the 3GFP_3NLS plasmid created in this study has a 
molecular weight of approximately 81,000 D which is large enough to inhibit simple 
diffusion, according to other studies by Paine (1975) and Kalderon et al. (1984) that showed 
proteins larger than approximately 70,000 Da are completely excluded from the nucleus.  It is 
known that proteins larger than 60, 000 Da can barely enter by passive diffusion. This why a 
protein that is 70,000 Da or more is excluded from the nucleus. This size cut-off to simple 
diffusion is a result of the NPC structure. However, In the presence of a nuclear localization 
signal (NLS), proteins of any size rapidly accumulate in the nucleus in high concentration 
(Keminer and Peters, 1999; Cook et al., 2007). 
 
One undesirable feature of the plasmid created by Chatterjee et al. (1997) is that it 
contains an inducible promoter, that is, a gene promoter that must be induced by a chemical 
inducer for gene expression to occur.  The promoter used in the Chatterjee et al. plasmid 
contains a glucocorticoid response element that requires dexamethasone for induction and 
eventual expression of GFP. The plasmid created in this research project is similar to the 
Chatterjee et al. plasmid, but it contains 3 copies of the GFP ORF linked to three tandemly- 
arranged NLSs (3GFP_3NLS) and controlled by a promoter that does not require chemical 
induction, resulting in the strong constitutive expression of the GFP fusion protein. 
Therefore, the 3GFP_3NLS plasmid created in this study is more preferable over the 
Chatterjee et al. (1997) plasmid because it does not require chemical induction to get the GFP 
 
fusion protein to be expressed.
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Based on the behavior of the fusion protein of the 1GFP_3NLS and 2GFP_3NLS 
plasmid, I expect the fusion protein of the 3GFP_3NLS plasmid to behave the same way in 
mammalian kidney cells when expressed. Fluoresce microscopy will be used to visualize the 
cellular location of the fusion proteins of each plasmid expressed in Human Embryonic 
Kidney (HEK) cells. The 1GFP_3NLS plasmid will be completely localized solely to the 
nucleus of the cells. In other words, the detection of GFP will be confined within the nucleus 
of the HEK cells, there will be no visible cytoplasmic fluorescence. The same will be 
observed for the fusion proteins expressed by the pSGKK10 (2GFP_3NLS plasmid) and 
pSGKK16 (3GFP_3NLS plasmid). These results are expected because all the fusion proteins 
created contain NLSs but also the protein produced from the 3GFP_3NLS plasmid is large 
enough to prevent the simple diffusion of GFP. As mentioned, prior studies performed by 
Bond (2014) and Krumpos (2014) showed that in the absence of an NLS (1GFP_0NLS), 
GFP appears in both the cytoplasm and nucleus of transfected Human Embryonic Kidney 
(HEK) Cells. Therefore it is expected that all these fusion proteins will be localized solely to 
the nucleus. The rate of nuclear importation of each expressed protein is inversely related to 
its molecular weight so the 1GFP_3NLS fusion protein will move into the nucleus the fastest, 
the 2GFP_3NLS fusion protein will be slower and the 3GFP_3NLS plasmid will be the 
slowest. These results will agree with the studies performed by Paine, Chatterjee and Cook et 
al. 
 
Many challenges were faced in the process of creating the 3GFP_3NLS plasmid, and 
four different strategies were used to generate it. The first strategy consisted of inserting the 
3
rd 
GFP ORF downstream of the original GFP ORF. The first step consisted of designing 
 
primers to insert a 48-base pair linker to pSGKK10 (2GFP_3NLS plasmid) downstream of
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the original GFP ORF and upstream of the NLSs. This 48-base pair linker would be used as a 
spacer separating the GFP ORF from the to-be-inserted third copy of the GFP ORF. The 
primers were successfully created, however this strategy failed due to overlap in the DNA 
sequence, because of the multiple GFP ORFs. The designed primers were not binding to the 
site of interest but to other DNA sequence. The second strategy employed was similar to the 
first, however the intention was to place the 48-base pair linker upstream of the second GFP 
ORF in pSGKK10 (2GFP_3NLS plasmid). This strategy also failed due to there being 
overlap in the DNA sequence due to the double GFPs in this 2GFP_3NLS plasmid. 
Mutagenesis to insert a 48bp linker upstream and downstream of the GFP genes, 
respectively, was unsuccessful due to overlapping in the sequences. Therefore Strategy one 
and two failed. 
 
Strategy three was completely different from the first two. This strategy consisted of 
designing a brand new insert plasmid that would contain the soon-to-be 3
rd 
GFP ORF insert 
and a 24 base pair linker. This was done by using the parent plasmid, pCMV/myc/nuc/GFP 
and inserting a 24 base pair linker downstream of the GFP ORF. This plasmid was 
successfully created and confirmed by sequencing. A new restriction digestion cut site also 
had to be used instead of the original cut site, Pst1, that was being used. This was done 
because the second-insert GFP ORF was flanked by two Pst1 cut sites. The chosen restriction 
digest cut site was Nco1 since the parent plasmid already contained one Nco1 cut site 
upstream of the GFP ORF; site-directed mutagenesis was used to insert a second Nco1 cut 
site downstream of the GFP ORF. However, strategy three failed because there was a Nco1 
 
cut site within the GFP gene, which was not known until the experiments were carried out.
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There was a lot of difficulty finding an adequate restriction digest enzyme because of issues 
such as methylation, multiple cut sites, and overlapping sequences. 
 
Finally, strategy four resulted in the creation of the 3GFP_3NLS plasmid. This 
strategy consisted of finding a restriction digest enzyme site that was not present anywhere in 
any of the plasmid’s genome and that did not require methylation. This enzyme was Pac1. 
This restriction digest cut site was then inserted once into pSGKK10 (2GFP_3NLS), the 
vector plasmid, and twice into the insert plasmid to flank the GFP ORF and the 24 bp linker. 
This procedure is described in the materials and methods section. This strategy proved to be 
successful in the creation of the 3GFP_3NLS plasmid designated pSGKK15. However, the 
insertion mutation of the Pac1 cut sites caused a frame shift mutation where the 2
nd 
and 3
rd
 
 
GFP ORFs were no longer in frame. This happened because the Pac1 cut site is 8 base pairs 
and DNA is read in triplets. However, to put the GFP ORFs back in frame a two base pair 
insertion mutation (5’CA3’) was done downstream of the 24 base pair. This plasmid was 
confirmed by DNA sequencing and re-designated pSGKK16 (3GFP_3NLS plasmid). 
 
Now that synthesis of the 3GFP_3NLS plasmid has been completed, a future study 
will involve removing 2 of the NLSs from the 3GFP_3NLS plasmid to produce the final 
3GFP_1NLS plasmid. This final plasmid, 3GFP_1NLS will contain all the necessary 
components to study the nuclear import process and the NLS, because in nature the normal 
physiological nuclear import process only requires the presence of one NLS.
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Appendix A 
 
CTGCAGATGGCTAGCAAAGGAGAAGAACTTTTCACTGGAGTTGTCCCAATTCTTGTTGAATTAGATGGTGATG 
TTAATGGGCACAAATTTTCTGTCAGTGGAGAGGGTGAAGGTGATGCTACATACGGAAAGCTTACCCTTAAATT 
TATTTGCACTACTGGAAAACTACCTGTTCCATGGCCAACACTTGTCACTACTTTCTCTTATGGTGTTCAATGCTT 
TTCCCGTTATCCGGATCATATGAAACGGCATGACTTTTTCAAGAGTGCCATGCCCGAAGGTTATGTACAGGAA 
CGCACTATATCTTTCAAAGATGACGGGAACTACAAGACGCGTGCTGAAGTCAAGTTTGAAGGTGATACCCTTG 
TTAATCGTATCGAGTTAAAAGGTATTGATTTTAAAGAAGATGGAAACATTCTCGGACACAAACTCGAGTACAA 
CTATAACTCACACAATGTATACATCACGGCAGACAAACAAAAGAATGGAATCAAAGCTAACTTCAAAATTCG 
CCACAACATTGAAGATGGATCCGTTCAACTAGCAGACCATTATCAACAAAATACTCCAATTGGCGATGGCCCT 
GTCCTTTTACCAGACAACCATTACCTGTCGACACAATCTGCCCTTTCGAAAGATCCCAACGAAAAGCGTGACC 
ACATGGTCCTTCTTGAGTTAGTTGTAACTGCTGCTGGGATTACACATGGCATGGATGAGCTCTACAAAGCGGC 
CGCAGATCCAAAAAAGAAGAGAAAGGTAGATCCAAAAAAGAAGAGAAAGGTAGATCCAAAAAAGAAGAGA 
AAGGTAGATACGGCCGCAGAACAAAAACTCATCTCAGAAGAGGATCTGAATGGGGCCGCATAG 
 
Figure 1. Sequence of the 1GFP-3NLS plasmid. Starting at the upstream 5’ end of the 
sequence is the Pst1 cut site (gray), followed by the GFP ORF (green), followed by the Not1 
cut site (dark red). Following the downstream original GFP ORF are the 3 NLSs (pink), 
along with other features of the plasmid.
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Figure 2a. 1% agarose gel electrophoresis showing pSGKK07, pSGKK09 and pSGKK10 
plasmids cut with Pst1. 
 
 
 
 
 
 
 
 
 
 
48 bp linker 
 
 
48 bp linker 
 
 
 
 
 
 
 
 
 
 
 
Figure 2b. Restriction Map step 1 and step 2 showing pSGKK07 and pSGKK09 cut with Pst1. 
Step 3 shows ligation of GFP ORF into the pSGKK07 (vector plasmid) to create pSGKK10 
(2GFP_3NLS plasmid).
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CTGCAGATGGCTAGCAAAGGAGAAGAACTTTTCACTGGAGTTGTCCCAATTCTTGTTGAATTAGATGGTGATG 
TTAATGGGCACAAATTTTCTGTCAGTGGAGAGGGTGAAGGTGATGCTACATACGGAAAGCTTACCCTTAAATT 
TATTTGCACTACTGGAAAACTACCTGTTCCATGGCCAACACTTGTCACTACTTTCTCTTATGGTGTTCAATGCTT 
TTCCCGTTATCCGGATCATATGAAACGGCATGACTTTTTCAAGAGTGCCATGCCCGAAGGTTATGTACAGGAA 
CGCACTATATCTTTCAAAGATGACGGGAACTACAAGACGCGTGCTGAAGTCAAGTTTGAAGGTGATACCCTTG 
TTAATCGTATCGAGTTAAAAGGTATTGATTTTAAAGAAGATGGAAACATTCTCGGACACAAACTCGAGTACAA 
CTATAACTCACACAATGTATACATCACGGCAGACAAACAAAAGAATGGAATCAAAGCTAACTTCAAAATTCG 
CCACAACATTGAAGATGGATCCGTTCAACTAGCAGACCATTATCAACAAAATACTCCAATTGGCGATGGCCCT 
GTCCTTTTACCAGACAACCATTACCTGTCGACACAATCTGCCCTTTCGAAAGATCCCAACGAAAAGCGTGACC 
ACATGGTCCTTCTTGAGTTTGTAACTGCTGCTGGGATTACACATGGCATGGATGAGCTCTACAAA CTGCAG GG 
TGGTTCTGGTGGTGGTTCTGGTGGTGGTTCTGGTGGTGGTTCTGGT ATGGCTAGCAAAGGAGAAGAACTTTTC 
ACTGGAGTTGTCCCAATTCTTGTTGAATTAGATGGTGATGTTAATGGGCACAAATTTTCTGTCAGTGGAGAGG 
GTGAAGGTGATGCTACATACGGAAAGCTTACCCTTAAATTTATTTGCACTACTGGAAAACTACCTGTTCCATG 
GCCAACACTTGTCACTACTTTCTCTTATGGTGTTCAATGCTTTTCCCGTTATCCGGATCATATGAAACGGCATG 
ACTTTTTCAAGAGTGCCATGCCCGAAGGTTATGTACAGGAACGCACTATATCTTTCAAAGATGACGGGAACTA 
CAAGACGCGTGCTGAAGTCAAGTTTGAAGGTGATACCCTTGTTAATCGTATCGAGTTAAAAGGTATTGATTTT 
AAAGAAGATGGAAACATTCTCGGACACAAACTCGAGTACAACTATAACTCACACAATGTATACATCACGGCA 
GACAAACAAAAGAATGGAATCAAAGCTAACTTCAAAATTCGCCACAACATTGAAGATGGATCCGTTCAACTA 
GCAGACCATTATCAACAAAATACTCCAATTGGCGATGGCCCTGTCCTTTTACCAGACAACCATTACCTGTCGA 
CACAATCTGCCCTTTCGAAAGATCCCAACGAAAAGCGTGACCACATGGTCCTTCTTGAGTTTGTAACTGCTGC 
TGGGATTACACATGGCATGGATGAGCTCTACAAAGCGGCCGCAGATCCAAAAAAGAAGAGAAAGGTAGATCC 
AAAAAAGAAGAGAAAGGTAGATCCAAAAAAGAAGAGAAAGGTAGATACGGCCGCAGAACAAAAACTCATCT 
CAGAAGAGGATCTGAATGGGCCGCAAGTCTGA 
 
Figure 3. Sequence of the 2GFP-3NLS plasmid (pSGKK10). Starting at the upstream 5’ end 
of the sequence is the Pst1 cut site 1 (gray), followed by the newly-inserted GFP ORF 
(green), followed by the Pst1 cut site 2 (gray), the 48 bp linker (yellow) and the original 
GFP ORF (green).  Following the downstream original GFP ORF are the 3 NLSs (pink), 
along with other features of the plasmid.
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Figure 4a. 1% agarose gel electrophoresis showing pSGKK12, pSGKK14 and pSGKK16 
plasmids cut with Pac1. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Step 1. pSGKK12 cut with Pac1           Step 2. pSGKK14 cut with Pac1                                Step 3. Ligation 
Figure 4b. Restriction Map. Step 1 and step 2 showing pSGKK12 and pSGKK14 cut with Pac1. 
Step 3 shows ligation of GFP ORF into the pSGKK12 (vector plasmid) to create pSGKK15 
(2GFP_3NLS plasmid).
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TTAATTAAACGTGGCCACCATGGCCCAGGTGCAGCTGCAGATGGCTAGCAAAGGAGAAGAACTTTTCACTGGAGTTGTCCCAATTCTTG 
TTGAATTAGATGGTGATGTTAATGGGCACAAATTTTCTGTCAGTGGAGAGGGTGAAGGTGATGCTACATACGGAAAGCTTACCCTTAAA 
TTTATTTGCACTACTGGAAAACTACCTGTTCCATGGCCAACACTTGTCACTACTTTCTCTTATGGTGTTCAATGCTTTTCCCGTTATCCGGA 
TCATATGAAACGGCATGACTTTTTCAAGAGTGCCATGCCCGAAGGTTATGTACAGGAACGCACTATATCTTTCAAAGATGACGGGAACT 
ACAAGACGCGTGCTGAAGTCAAGTTTGAAGGTGATACCCTTGTTAATCGTATCGAGTTAAAAGGTATTGATTTTAAAGAAGATGGAAAC 
ATTCTCGGACACAAACTCGAGTACAACTATAACTCACACAATGTATACATCACGGCAGACAAACAAAAGAATGGAATCAAAGCTAACTT 
CAAAATTCGCCACAACATTGAAGATGGATCCGTTCAACTAGCAGACCATTATCAACAAAATACTCCAATTGGCGATGGCCCTGTCCTTTT 
ACCAGACAACCATTACCTGTCGACACAATCTGCCCTTTCGAAAGATCCCAACGAAAAGCGTGACCACATGGTCCTTCTTGAGTTTGTAAC 
TGCTGCTGGGATTACACATGGCATGGATGAGCTCTACAAAGCGGCCGCAGGTGGTTCTGGTGGTGGTTCTGGCATTTAATTAAACGTG 
GCCACCATGGCCCAGGTGCAGCTGCAGATGGCTAGCAAAGGAGAAGAACTTTTCACTGGAGTTGTCCCAATTCTTGTTGAATTAGATGG 
TGATGTTAATGGGCACAAATTTTCTGTCAGTGGAGAGGGTGAAGGTGATGCTACATACGGAAAGCTTACCCTTAAATTTATTTGCACTA 
CTGGAAAACTACCTGTTCCATGGCCAACACTTGTCACTACTTTCTCTTATGGTGTTCAATGCTTTTCCCGTTATCCGGATCATATGAAACG 
GCATGACTTTTTCAAGAGTGCCATGCCCGAAGGTTATGTACAGGAACGCACTATATCTTTCAAAGATGACGGGAACTACAAGACGCGTG 
CTGAAGTCAAGTTTGAAGGTGATACCCTTGTTAATCGTATCGAGTTAAAAGGTATTGATTTTAAAGAAGATGGAAACATTCTCGGACAC 
AAACTCGAGTACAACTATAACTCACACAATGTATACATCACGGCAGACAAACAAAAGAATGGAATCAAAGCTAACTTCAAAATTCGCCA 
CAACATTGAAGATGGATCCGTTCAACTAGCAGACCATTATCAACAAAATACTCCAATTGGCGATGGCCCTGTCCTTTTACCAGACAACCA 
TTACCTGTCGACACAATCTGCCCTTTCGAAAGATCCCAACGAAAAGCGTGACCACATGGTCCTTCTTGAGTTTGTAACTGCTGCTGGGAT 
TACACATGGCATGGATGAGCTCTACAAACTGCAGGGTGGTTCTGGTGGTGGTTCTGGTGGTGGTTCTGGTGGTGGTTCTGGTATGGCT 
AGCAAAGGAGAAGAACTTTTCACTGGAGTTGTCCCAATTCTTGTTGAATTAGATGGTGATGTTAATGGGCACAAATTTTCTGTCAGTGG 
AGAGGGTGAAGGTGATGCTACATACGGAAAGCTTACCCTTAAATTTATTTGCACTACTGGAAAACTACCTGTTCCATGGCCAACACTTGT 
CACTACTTTCTCTTATGGTGTTCAATGCTTTTCCCGTTATCCGGATCATATGAAACGGCATGACTTTTTCAAGAGTGCCATGCCCGAAGGT 
TATGTACAGGAACGCACTATATCTTTCAAAGATGACGGGAACTACAAGACGCGTGCTGAAGTCAAGTTTGAAGGTGATACCCTTGTTAA 
TCGTATCGAGTTAAAAGGTATTGATTTTAAAGAAGATGGAAACATTCTCGGACACAAACTCGAGTACAACTATAACTCACACAATGTATA 
CATCACGGCAGACAAACAAAAGAATGGAATCAAAGCTAACTTCAAAATTCGCCACAACATTGAAGATGGATCCGTTCAACTAGCAGACC 
ATTATCAACAAAATACTCCAATTGGCGATGGCCCTGTCCTTTTACCAGACAACCATTACCTGTCGACACAATCTGCCCTTTCGAAAGATCC 
CAACGAAAAGCGTGACCACATGGTCCTTCTTGAGTTTGTAACTGCTGCTGGGATTACACATGGCATGGATGAGCTCTACAAAGCGGCCG 
GCGGCCGCAGATCCAAAAAAGAAGAGAAAGGTAGATCCAAAAAAGAAGAGAAAGGTAGATCCAAAAAAGAAGAGAAAGGTAGATAC 
GGCCGCAGAACAAAAACTCATCTCAGAAGAGGATCTGAATGGGGCCGCATAG 
 
Figure 5. Sequence of the 3GFP-3NLS plasmid (pSGKK15). Starting at the upstream 5’ end 
of the sequence is the Pac1 cut site 1 (purple), Pst1 cut site 1 (gray), followed by the newly- 
inserted GFP ORF (green), followed by a Not1 cut site 1 (dark red), 24bp pair linker 
(yellow), Pac 1 cut site 2 (purple), the Pst1 cut site 2 (gray),followed by the second GFP 
ORF (green), Pst1 cut site 3 (gray), the 48 bp linker (yellow) and the original GFP ORF 
(green).  Following the downstream original GFP ORF are the 3 NLSs (pink), along with 
other features of the plasmid.
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Appendix B 
 
 
Q5
® 
Site-Directed Mutagenesis Kit Quick Protocol (New England BioLabs, 
E0554) 
 
Step 1: Exponential Amplification 
 
Component 25 μl RXN FINAL CONC. 
Q5 Hot Start High-Fidelity 2X Master Mix 12.5 μl 1X 
10 μM Forward Primer 1.25 μl 0.5 μM 
10 μM Reverse Primer 1.25 μl 0.5 μM 
Template DNA (1–25 ng/μl) 1 μl 1-25 ng 
Nuclease-free water 9.0 μl  
 
Cycling Conditions: 
 
STEP TEMP TIME 
Initial Denaturation 98°C 30 seconds 
25 Cycles 98°C 10 seconds 
50–72°C* 10–30 seconds 
72°C 20–30 seconds/kb (3:00 mins) 
Final Extension 72°C 2 minutes 
Hold 4–10°C  
* For mutagenic primers, please use the Ta provided by the online NEB primer 
design software,  NEBaseChanger™. 
 
Step 2: KLD Reaction 
 
Component VOLUME FINAL CONC. 
PCR Product 1 μl  
2X KLD Reaction Buffer 5 μl 1X 
10X KLD Enzyme Mix 1 μl 1X 
Nuclease-free Water 3 μl  
Incubate for 5 minutes at room temperature. 
 
Step 3: Transformation 
 
1.   Add 5 μl of KLD mix to 50 μl of chemically-competent cells. 
2.   Incubate on ice for 30 minutes. 
3.   Heat shock at 42°C for 30 seconds. 
4.   Incubate on ice for 5 minutes.
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5.   Add 950 μl SOC, gently shake at 37°C for 1 hour. 
6.   Spread 40–100 μl onto appropriate selection plate, incubate overnight at 37°C. 
 
GeneJET Plasmid Miniprep Kit Protocol (ThermoFisher Scientific, K0502) 
 
Note: all purification steps should be carried out at room temperature. All centrifugations 
should be carried out in a table-top microcentrifuge at 13,000 rpm. Use 3 mL of E. coli culture 
in LB+AMP media for purification of high-copy plasmids. Add 1.5 mL E. coli culture in 
LB+AMP media to a microcentrifuge tube and centrifuge for 3 minutes at 13,000 rpm, repeat 
this step twice with all culture tubs. 
 
Plasmid DNA purification using centrifuges 
Step Procedure 
1 Resuspend the pelleted cells in 250 µL of the Resuspension Solution. Transfer 
the cell suspension to a microcentrifuge tube. The bacteria should be resuspended 
completely by vortexing or pipetting up and down until no cell clumps remain. 
Note. Ensure RNase A has been added to the Resuspension Solution 
2 Add 250 µL of the Lysis Solution and mix thoroughly by inverting the tube 4-6 
times until the solution becomes viscous and slightly clear. 
Note. Do not vortex to avoid shearing of chromosomal DNA. Do not incubate for more than 5 min 
to avoid denaturation of supercoiled plasmid DNA. 
3 Add 350 µL of the Neutralization Solution and mix immediately and thoroughly 
by inverting the tube 4-6 times. 
Note. It is important to mix thoroughly and gently after the addition of the Neutralization Solution 
to avoid localized precipitation of bacterial cell debris. The neutralized bacterial lysate should 
become cloudy. 
4 Centrifuge for 5 min to pellet cell debris and chromosomal DNA. 
5 Transfer the supernatant to the supplied GeneJET spin column by decanting or 
pipetting. Avoid disturbing or transferring the white precipitate. 
Note. Close the bag with GeneJET Spin Columns tightly after each use! 
6 Centrifuge for 1 min. Discard the flow-through and place the column back into the 
same collection tube. 
Note. Do not add bleach to the flow-through 
7 Add 500 µL of the Wash Solution to the GeneJET spin column. Centrifuge for 
60 seconds and discard the flow-through. Place the column back into the same 
collection tube. 
8 Repeat the wash procedure (step 7) using 500 µL of the Wash Solution. 
9 Discard the flow-through and centrifuge for an additional 1 min to remove 
residual Wash Solution. This step is essential to avoid residual ethanol in plasmid 
preps. 
10 Transfer the GeneJET spin column into a fresh 1.5 mL microcentrifuge tube. Add 
30 µL of the Elution Buffer to the center of GeneJET spin column membrane to 
elute the plasmid DNA. Take care not to contact the membrane with the pipette 
tip. Incubate for 2 min at room temperature and centrifuge for 2 min. 
11 Discard the column and store the purified plasmid DNA at -20°C. 
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QIAquick Gel Extraction Kit (Quiagen, 28706) 
 
The following protocol has been revised from the standard QIAquick instructions found in the 
QIAquick Spin Handbook and is to be used for all Gallik Gel Extractions. The protocol is 
designed to extract and purify DNA of 70 bp to 10 kb from standard or low-melt agarose gels 
in TAE or TBE buffer. Gallik lab always runs 1% agarose gels. Up to 400mg agarose can be 
processed per spin column. 
 
Important points before starting 
  The yellow color of Buffer QG indicates a pH ≤7.5. 
  Add ethanol (96–100%) to Buffer PE before use (see bottle label for volume). 
  All centrifugation steps are carried out at 13,000 rpm in a conventional table-top 
 
Procedure 
 
1. Excise the DNA fragment from the agarose gel with a clean, sharp scalpel. 
a. Minimize the size of the gel slice by removing extra agarose from the excised fragment. 
 
2. Weigh the gel slice in a colorless microcentrifuge tube. Then add 3 volumes of Buffer QG 
to 1 volume of gel. 
a. For example, add 300 μl of Buffer QG to each 100 mg of gel. For >2% agarose gels, add 
6 volumes of Buffer QG. The maximum amount of gel slice per QIAquick column is 400 
mg; for gel slices >400 mg use more than one QIAquick column. 
 
3. Incubate at 50°C for 15 min (or until the gel slice has completely dissolved) in a water bath. 
Mix the tube by vortexing and finger flicking every 2 minutes. 
a.   For >2% gels, increase incubation time. 
 
4. After the gel slice has dissolved completely, check that the color of the mixture is yellow 
(similar to Buffer QG without dissolved agarose). 
a.   If the color of the mixture is orange or violet. 
 
5. SKIP step 5 (isopropanol step) as it appears in the QIAquick Spin Handbook. 
 
6. Place a QIAquick spin column in a provided 2 ml collection tube. 
 
7. Apply the sample to the QIAquick column, and centrifuge for 1 min. 
a. The maximum volume of the column reservoir is 800 μl. For sample volumes of more 
than 800 μl, simply split up the sample, load and spin again. 
 
8. Discard flow-through and place QIAquick column back in the same collection tube. 
a. Collection tubes are reused to reduce plastic waste. 
 
9. SKIP step 9 as it appears in the QIAquick Spin Handbook.
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10. To wash, add 0.75 ml of Buffer PE to QIAquick column, centrifuge for 1 min, discard the 
flowthrough, then let the column stand for 3 minutes with the top open to allow residual 
ethanol to evaporate. Then centrifuge the QIAquick column for an additional 1min at 13,000 
rpm. 
 
11. Repeat Step 10. 
 
12. After it has been washed twice, place QIAquick column into a clean 1.5 ml 
microcentrifuge tube. 
 
13. To elute the DNA, add 30 μl elution buffer to the center of the QIAquick membrane, let 
the column stand for 3 min, and then centrifuge for 1 min. 
a. IMPORTANT: Ensure that the elution buffer is dispensed directly onto the QIAquick 
membrane for complete elution of bound DNA. The average eluate volume is 48 μl from 50 μl 
elution buffer volume, and 28 μl from 30 μl. 
b. Elution efficiency is dependent on pH. The maximum elution efficiency is achieved 
between pH 7.0 and 8.5.When using water, make sure that the pH value is within this range, 
and store DNA at –20°C as DNA may degrade in the absence of a buffering agent. The 
purified DNA can also be eluted in TE buffer (10 mM Tris·Cl, 1 mM EDTA, pH 8.0), but the 
EDTA may inhibit subsequent enzymatic reactions. 
 
14. If the purified DNA is to be analyzed on a gel, add 1 volume of the restriction digest 
loading dye to 5 volumes of purified DNA. Mix the solution by pipetting up and down before 
loading the gel. 
a. The restriction digest loading dye will, among other things, deactivate the restriction 
enzyme. 
Calculate Expected DNA Yield from gel extraction: 
Basic Formula: 
((total ng of DNA added to well × fraction of vector taken up by the insert) / 30μl) X 0.95 
 
Explanation: 
Given that 20 μl sample containing x μg DNA in gel well (sample from Miniprep) 
1.   Calculate the fraction of the entire vector that makes up the DNA fragment of interest 
(insert) in decimal. 
 
Example: GFP insert from pSGKK09 is 0.126 of the total vector (717b / 5700 b). 
 
2.   Calculate the fraction of the mass of DNA in the sample (x μg) that makes up the DNA 
fragment. 
 
Example from above: 0.126 x 2.4μg = 0.302μg = 302ng of insert DNA in the sample. 
This means that ideally, when you excise the insert band from the gel, there are 302 ng of 
insert DNA in the band. When you proceed with the gel extraction, ideally 302 ng insert DNA 
will bind to the membrane.
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3. In the gel extraction, you elute the 302 ng with 30μl elutant buffer, that is 302ng / 30μl, 
which is 10ng DNA / μl. Considering 95% recovery (ideally), 10ng/μl x 0.95 = 9.6ng/μl yield 
with gel extraction. 
 
 
Ligation Protocol with T4 DNA Ligase (New England Biolabs, M0202) 
 
1.   Set up the following reaction in a microcentrifuge tube on ice. 
(T4 DNA Ligase should be added last. Note that the table shows a ligation using a molar 
ratio of 1:3 vector to insert for the indicated DNA sizes.) Use NEBioCalculator to 
calculate molar ratios. 
 
COMPONENT 20 μl REACTION 
10X T4 DNA Ligase Buffer* 2 μl 
Vector DNA (4 kb) 50 ng (0.020 pmol) 
Insert DNA (1 kb) 37.5 ng (0.060 pmol) 
Nuclease-free water to 20 μl 
T4 DNA Ligase 1 μl 
* The T4 DNA Ligase Buffer should be thawed and resuspended at room temperature. 
 
2.   Gently mix the reaction by pipetting up and down and microfuge briefly. 
 
 
3.   For cohesive (sticky) ends, incubate at 16°C overnight or room temperature for 10 
minutes. 
 
4.   Heat inactivate at 65°C for 10 minutes. 
 
5.   Chill on ice and transform 3 μl of the reaction into 50 μl competent cells. 
